

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.41582604 |
| 2 | presynaptic membrane assembly (GO:0097105) | 4.44170238 |
| 3 | postsynaptic membrane organization (GO:0001941) | 4.39566181 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16740518 |
| 5 | positive regulation of protein kinase C signaling (GO:0090037) | 4.08140701 |
| 6 | presynaptic membrane organization (GO:0097090) | 3.94772759 |
| 7 | response to muramyl dipeptide (GO:0032495) | 3.80275382 |
| 8 | short-term memory (GO:0007614) | 3.77499303 |
| 9 | metanephric nephron tubule development (GO:0072234) | 3.55491925 |
| 10 | metanephric tubule development (GO:0072170) | 3.55491925 |
| 11 | neuronal action potential propagation (GO:0019227) | 3.48729221 |
| 12 | * mannose metabolic process (GO:0006013) | 3.48599535 |
| 13 | facial nerve structural organization (GO:0021612) | 3.47161496 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46558543 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42990848 |
| 16 | regulation of pigment cell differentiation (GO:0050932) | 3.35842169 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.34002088 |
| 18 | metanephric nephron epithelium development (GO:0072243) | 3.32855251 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.26161239 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16272811 |
| 21 | metanephric epithelium development (GO:0072207) | 3.11783153 |
| 22 | germinal center formation (GO:0002467) | 3.11435045 |
| 23 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.02722378 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 3.00598514 |
| 25 | response to peptidoglycan (GO:0032494) | 3.00178310 |
| 26 | negative regulation of cell killing (GO:0031342) | 2.95140040 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95140040 |
| 28 | detection of bacterium (GO:0016045) | 2.93135207 |
| 29 | regulation of protein kinase C signaling (GO:0090036) | 2.92565156 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91918334 |
| 31 | cranial nerve structural organization (GO:0021604) | 2.91653617 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.90895922 |
| 33 | response to laminar fluid shear stress (GO:0034616) | 2.87904080 |
| 34 | detection of other organism (GO:0098543) | 2.87722092 |
| 35 | T cell selection (GO:0045058) | 2.86380140 |
| 36 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.86314555 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85263808 |
| 38 | positive regulation of histone deacetylation (GO:0031065) | 2.84576235 |
| 39 | negative thymic T cell selection (GO:0045060) | 2.84174352 |
| 40 | nephron epithelium development (GO:0072009) | 2.83897900 |
| 41 | calcium ion import (GO:0070509) | 2.81998068 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81629339 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79895208 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 2.79895208 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79895208 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79895208 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79895208 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 2.79895208 |
| 49 | positive thymic T cell selection (GO:0045059) | 2.79278264 |
| 50 | androgen biosynthetic process (GO:0006702) | 2.78982272 |
| 51 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76841642 |
| 52 | glycine transport (GO:0015816) | 2.75440903 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 2.70097867 |
| 54 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.69929903 |
| 55 | positive regulation of Rap GTPase activity (GO:0032854) | 2.69539573 |
| 56 | regulation of protein kinase A signaling (GO:0010738) | 2.69254682 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 2.69254395 |
| 58 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69136755 |
| 59 | negative regulation of cell size (GO:0045792) | 2.67990909 |
| 60 | endothelium development (GO:0003158) | 2.64304981 |
| 61 | long-term memory (GO:0007616) | 2.63831748 |
| 62 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.62613373 |
| 63 | mature B cell differentiation (GO:0002335) | 2.61943063 |
| 64 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.59140785 |
| 65 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.58942568 |
| 66 | negative T cell selection (GO:0043383) | 2.58854692 |
| 67 | activation of JUN kinase activity (GO:0007257) | 2.55971559 |
| 68 | positive regulation of dendritic spine development (GO:0060999) | 2.55842917 |
| 69 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55682330 |
| 70 | central nervous system myelination (GO:0022010) | 2.53873389 |
| 71 | axon ensheathment in central nervous system (GO:0032291) | 2.53873389 |
| 72 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.53381435 |
| 73 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.53381435 |
| 74 | protein heterotetramerization (GO:0051290) | 2.52998546 |
| 75 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.52778194 |
| 76 | leukocyte aggregation (GO:0070486) | 2.52291791 |
| 77 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.52254030 |
| 78 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.50277086 |
| 79 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.48145033 |
| 80 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.46834735 |
| 81 | melanin metabolic process (GO:0006582) | 2.46826144 |
| 82 | histone H4 deacetylation (GO:0070933) | 2.46395009 |
| 83 | G-protein coupled receptor internalization (GO:0002031) | 2.46331718 |
| 84 | cyclic nucleotide catabolic process (GO:0009214) | 2.44356507 |
| 85 | left/right pattern formation (GO:0060972) | 2.44114765 |
| 86 | cAMP catabolic process (GO:0006198) | 2.43940087 |
| 87 | endothelial cell chemotaxis (GO:0035767) | 2.42795798 |
| 88 | central nervous system neuron axonogenesis (GO:0021955) | 2.42621228 |
| 89 | cranial nerve morphogenesis (GO:0021602) | 2.42448114 |
| 90 | import into cell (GO:0098657) | 2.40768255 |
| 91 | detection of external biotic stimulus (GO:0098581) | 2.40215377 |
| 92 | positive regulation of protein deacetylation (GO:0090312) | 2.39508071 |
| 93 | cell differentiation involved in metanephros development (GO:0072202) | 2.39238954 |
| 94 | histone H3 deacetylation (GO:0070932) | 2.38929482 |
| 95 | regulation of histone H3-K27 methylation (GO:0061085) | 2.38550842 |
| 96 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38151064 |
| 97 | positive T cell selection (GO:0043368) | 2.37890424 |
| 98 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.37060601 |
| 99 | embryonic process involved in female pregnancy (GO:0060136) | 2.36973197 |
| 100 | negative regulation of fatty acid transport (GO:2000192) | 2.36773869 |
| 101 | adaptation of signaling pathway (GO:0023058) | 2.36756258 |
| 102 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.35538254 |
| 103 | organ growth (GO:0035265) | 2.34902848 |
| 104 | regulation of leukocyte degranulation (GO:0043300) | 2.34426570 |
| 105 | tolerance induction (GO:0002507) | 2.34261294 |
| 106 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.33273589 |
| 107 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.33230296 |
| 108 | regulation of ARF GTPase activity (GO:0032312) | 2.32988219 |
| 109 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.31895840 |
| 110 | activation of MAPKKK activity (GO:0000185) | 2.31880290 |
| 111 | regulation of p38MAPK cascade (GO:1900744) | 2.31838792 |
| 112 | amino acid import (GO:0043090) | 2.31610482 |
| 113 | negative regulation of innate immune response (GO:0045824) | 2.31499981 |
| 114 | developmental pigmentation (GO:0048066) | 2.31160022 |
| 115 | omega-hydroxylase P450 pathway (GO:0097267) | 2.30998808 |
| 116 | regulation of necroptotic process (GO:0060544) | 2.30040973 |
| 117 | B cell receptor signaling pathway (GO:0050853) | 2.29685711 |
| 118 | apoptotic process involved in morphogenesis (GO:0060561) | 2.29537758 |
| 119 | modulation by symbiont of host cellular process (GO:0044068) | 2.28074794 |
| 120 | response to fluid shear stress (GO:0034405) | 2.27760368 |
| 121 | stress fiber assembly (GO:0043149) | 2.27757814 |
| 122 | negative regulation of myotube differentiation (GO:0010832) | 2.27553772 |
| 123 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.27224760 |
| 124 | regulation of timing of cell differentiation (GO:0048505) | 2.26341633 |
| 125 | histone H3-K36 demethylation (GO:0070544) | 2.26180645 |
| 126 | positive regulation of receptor recycling (GO:0001921) | 2.25795488 |
| 127 | nephron tubule development (GO:0072080) | 2.25752181 |
| 128 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.25380772 |
| 129 | cornea development in camera-type eye (GO:0061303) | 2.24879522 |
| 130 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.24780064 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 2.24488322 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.24305841 |
| 133 | modulation by virus of host process (GO:0019054) | 2.23517334 |
| 134 | adherens junction assembly (GO:0034333) | 2.22578015 |
| 135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.22395984 |
| 136 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.21702370 |
| 137 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.21476604 |
| 138 | signal complex assembly (GO:0007172) | 2.21037194 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 2.20719779 |
| 140 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.20714064 |
| 141 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.20685436 |
| 142 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.20316735 |
| 143 | positive regulation of cholesterol efflux (GO:0010875) | 2.19011197 |
| 144 | focal adhesion assembly (GO:0048041) | 2.18788033 |
| 145 | cell-substrate adherens junction assembly (GO:0007045) | 2.18788033 |
| 146 | detection of biotic stimulus (GO:0009595) | 2.18106689 |
| 147 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.17758905 |
| 148 | neuron remodeling (GO:0016322) | 2.17351948 |
| 149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.16978472 |
| 150 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.16770898 |
| 151 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.16719109 |
| 152 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.16391752 |
| 153 | L-amino acid import (GO:0043092) | 2.16256926 |
| 154 | cerebellar Purkinje cell layer development (GO:0021680) | 2.16233700 |
| 155 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.16011706 |
| 156 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.15712813 |
| 157 | adenosine receptor signaling pathway (GO:0001973) | 2.14945429 |
| 158 | regulation of mast cell degranulation (GO:0043304) | 2.14752623 |
| 159 | Golgi to endosome transport (GO:0006895) | 2.14350438 |
| 160 | RNA destabilization (GO:0050779) | 2.14238630 |
| 161 | cell-cell junction maintenance (GO:0045217) | 2.14117734 |
| 162 | regulation of monocyte differentiation (GO:0045655) | 2.13431947 |
| 163 | cellular extravasation (GO:0045123) | 2.13396745 |
| 164 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.12935189 |
| 165 | negative regulation of muscle hypertrophy (GO:0014741) | 2.11909717 |
| 166 | regulation of Rap GTPase activity (GO:0032317) | 2.11174735 |
| 167 | melanin biosynthetic process (GO:0042438) | 2.11013297 |
| 168 | cellular response to epinephrine stimulus (GO:0071872) | 2.10720058 |
| 169 | barbed-end actin filament capping (GO:0051016) | 2.10054377 |
| 170 | membrane depolarization during action potential (GO:0086010) | 2.08331717 |
| 171 | regulation of antigen processing and presentation (GO:0002577) | 2.07978692 |
| 172 | positive regulation of calcium ion import (GO:0090280) | 2.07920319 |
| 173 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.07769364 |
| 174 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.07673621 |
| 175 | vocalization behavior (GO:0071625) | 2.06632061 |
| 176 | response to folic acid (GO:0051593) | 2.05867847 |
| 177 | forebrain neuron differentiation (GO:0021879) | 2.04517150 |
| 178 | renal tubule development (GO:0061326) | 2.03252559 |
| 179 | oligodendrocyte differentiation (GO:0048709) | 2.00507797 |
| 180 | polyol transport (GO:0015791) | 2.00205043 |
| 181 | phospholipid scrambling (GO:0017121) | 1.99386127 |
| 182 | thymic T cell selection (GO:0045061) | 1.99212599 |
| 183 | regulation of ARF protein signal transduction (GO:0032012) | 1.99160147 |
| 184 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.97605753 |
| 185 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.97605753 |
| 186 | autophagic vacuole fusion (GO:0000046) | 1.96820393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.21288661 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.65839321 |
| 3 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.56337155 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48646704 |
| 5 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46634209 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32874017 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.30738956 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29547549 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24232261 |
| 10 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21363205 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20749786 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16749091 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16122369 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15820983 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14682771 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.13276415 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12680433 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12680433 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11775161 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10102729 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05827849 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.03573765 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.03410491 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.03007770 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99831950 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.93455249 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92841835 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90752610 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89488649 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.84969196 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79380580 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79175636 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78733304 |
| 34 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73740671 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.72867566 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71840302 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67410658 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.66275189 |
| 39 | * P68_20966046_ChIP-Seq_HELA_Human | 1.63785900 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63404846 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59927783 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59045661 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54126857 |
| 44 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.49865254 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43877164 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43831885 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41735937 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40613276 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39395875 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38480109 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38241062 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38062905 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37961955 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37458325 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.36655966 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34863456 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34374952 |
| 58 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33033765 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32885372 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32030159 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31878335 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31664605 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28829896 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27705268 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26176750 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26152256 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25928447 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25721780 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25434327 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24044609 |
| 71 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24043916 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22860212 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21772997 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21329985 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19976238 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19430268 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17802157 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16940068 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16416374 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16414087 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16363516 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13626772 |
| 83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.12886966 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12677173 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12631035 |
| 86 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12111884 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11941852 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11123963 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09509668 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09224657 |
| 91 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09219493 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09203426 |
| 93 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.08432338 |
| 94 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.07673294 |
| 95 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07584437 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06818929 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06788215 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06684462 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06241890 |
| 100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06077006 |
| 101 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05615719 |
| 102 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05357882 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05178479 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04169917 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03975426 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03712265 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03311752 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02015167 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00961641 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00563381 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00416510 |
| 112 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.00300656 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99805220 |
| 114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98672608 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98661548 |
| 116 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97597968 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97133448 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97113021 |
| 119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96947476 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95710092 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95261503 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92331123 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.91783940 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90746341 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90555082 |
| 126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89828630 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89179478 |
| 128 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86581757 |
| 129 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85977197 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85119656 |
| 131 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84668085 |
| 132 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83940776 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83696802 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83578551 |
| 135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82545360 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82276168 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.82271309 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82175951 |
| 139 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.81753513 |
| 140 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81093792 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80813131 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80804519 |
| 143 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80707316 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80655300 |
| 145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80461491 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79915592 |
| 147 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79861563 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78484257 |
| 149 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77299955 |
| 150 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.76759399 |
| 151 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76612523 |
| 152 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76437475 |
| 153 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75658348 |
| 154 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74871299 |
| 155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74704334 |
| 156 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.73499748 |
| 157 | SA1_27219007_Chip-Seq_Bcells_Human | 0.73210939 |
| 158 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72803509 |
| 159 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.72767984 |
| 160 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.72725817 |
| 161 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.72513017 |
| 162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72301506 |
| 163 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72278414 |
| 164 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72250885 |
| 165 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.71903617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.47387021 |
| 2 | MP0005409_darkened_coat_color | 4.39798364 |
| 3 | MP0004381_abnormal_hair_follicle | 3.89990083 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.83927958 |
| 5 | MP0001188_hyperpigmentation | 3.37402248 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.29877682 |
| 7 | MP0000015_abnormal_ear_pigmentation | 3.26768325 |
| 8 | MP0003303_peritoneal_inflammation | 3.01403831 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.90859158 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.56098895 |
| 11 | MP0003724_increased_susceptibility_to | 2.52869581 |
| 12 | MP0005670_abnormal_white_adipose | 2.51987265 |
| 13 | MP0009278_abnormal_bone_marrow | 2.46363110 |
| 14 | MP0009840_abnormal_foam_cell | 2.11283535 |
| 15 | MP0003880_abnormal_central_pattern | 2.00083178 |
| 16 | MP0006292_abnormal_olfactory_placode | 1.94007540 |
| 17 | MP0003279_aneurysm | 1.92781070 |
| 18 | MP0000685_abnormal_immune_system | 1.91503515 |
| 19 | MP0005076_abnormal_cell_differentiation | 1.87867325 |
| 20 | MP0004947_skin_inflammation | 1.86256334 |
| 21 | MP0004742_abnormal_vestibular_system | 1.85653244 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.85373789 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.84199935 |
| 24 | MP0001849_ear_inflammation | 1.84143333 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.82695299 |
| 26 | MP0005451_abnormal_body_composition | 1.77434756 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.76050548 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.70451179 |
| 29 | MP0001958_emphysema | 1.69462452 |
| 30 | MP0000751_myopathy | 1.62454512 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.59473736 |
| 32 | MP0004510_myositis | 1.58963150 |
| 33 | MP0004859_abnormal_synaptic_plasticity | 1.57076384 |
| 34 | MP0003091_abnormal_cell_migration | 1.56755362 |
| 35 | MP0003329_amyloid_beta_deposits | 1.51388545 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.49849329 |
| 37 | MP0008569_lethality_at_weaning | 1.43675183 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.43314929 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.43115494 |
| 40 | MP0001819_abnormal_immune_cell | 1.42333051 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.42230766 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.41680355 |
| 43 | MP0006082_CNS_inflammation | 1.40457643 |
| 44 | MP0001873_stomach_inflammation | 1.38569496 |
| 45 | MP0000604_amyloidosis | 1.37403049 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.35833443 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.35293321 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.34752070 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.34752070 |
| 50 | MP0003635_abnormal_synaptic_transmissio | 1.33661918 |
| 51 | MP0002405_respiratory_system_inflammati | 1.33472271 |
| 52 | MP0005671_abnormal_response_to | 1.32441646 |
| 53 | MP0001486_abnormal_startle_reflex | 1.31091390 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.30822332 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.30129485 |
| 56 | MP0009745_abnormal_behavioral_response | 1.28450641 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.26632616 |
| 58 | MP0005360_urolithiasis | 1.24033143 |
| 59 | MP0004858_abnormal_nervous_system | 1.23643991 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.21912126 |
| 61 | MP0002095_abnormal_skin_pigmentation | 1.21698760 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.21602690 |
| 63 | MP0002272_abnormal_nervous_system | 1.21565555 |
| 64 | MP0003879_abnormal_hair_cell | 1.21471636 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.21300780 |
| 66 | MP0009046_muscle_twitch | 1.21126073 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.19709769 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.18743694 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.15696438 |
| 70 | MP0002064_seizures | 1.15609805 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.15428034 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.15401529 |
| 73 | MP0000858_altered_metastatic_potential | 1.14868006 |
| 74 | MP0000716_abnormal_immune_system | 1.13359518 |
| 75 | MP0002398_abnormal_bone_marrow | 1.12158364 |
| 76 | MP0005387_immune_system_phenotype | 1.11865232 |
| 77 | MP0001790_abnormal_immune_system | 1.11865232 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.10531512 |
| 79 | MP0008260_abnormal_autophagy | 1.09665349 |
| 80 | MP0001970_abnormal_pain_threshold | 1.08529931 |
| 81 | MP0000767_abnormal_smooth_muscle | 1.08338840 |
| 82 | MP0009785_altered_susceptibility_to | 1.07408568 |
| 83 | MP0002909_abnormal_adrenal_gland | 1.07298819 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.05008883 |
| 85 | MP0002177_abnormal_outer_ear | 1.04422681 |
| 86 | MP0005410_abnormal_fertilization | 1.04215293 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.02898398 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 1.02739369 |
| 89 | MP0004142_abnormal_muscle_tone | 1.02596566 |
| 90 | MP0004270_analgesia | 1.02358223 |
| 91 | MP0001851_eye_inflammation | 1.01778462 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.01124974 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 1.00560666 |
| 94 | MP0001853_heart_inflammation | 1.00078172 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.99448243 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.98978751 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.98606413 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.97638842 |
| 99 | MP0005390_skeleton_phenotype | 0.97395415 |
| 100 | MP0003075_altered_response_to | 0.97295999 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.95533129 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.95398683 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.94859800 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.94533261 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.94197577 |
| 106 | MP0000249_abnormal_blood_vessel | 0.92989863 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 0.91344052 |
| 108 | MP0002429_abnormal_blood_cell | 0.91297358 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.91071631 |
| 110 | MP0006138_congestive_heart_failure | 0.90557385 |
| 111 | MP0000920_abnormal_myelination | 0.90505873 |
| 112 | MP0003436_decreased_susceptibility_to | 0.89862558 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.89549394 |
| 114 | MP0000703_abnormal_thymus_morphology | 0.88798745 |
| 115 | MP0002822_catalepsy | 0.88533235 |
| 116 | MP0008469_abnormal_protein_level | 0.87805999 |
| 117 | MP0000733_abnormal_muscle_development | 0.87381659 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.87027534 |
| 119 | MP0000579_abnormal_nail_morphology | 0.86607950 |
| 120 | MP0002722_abnormal_immune_system | 0.86340775 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.85473401 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.84760727 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.83452777 |
| 124 | MP0002572_abnormal_emotion/affect_behav | 0.81894491 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.81875272 |
| 126 | MP0001270_distended_abdomen | 0.81624402 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.81534643 |
| 128 | MP0001664_abnormal_digestion | 0.81333935 |
| 129 | MP0005025_abnormal_response_to | 0.81301923 |
| 130 | MP0002249_abnormal_larynx_morphology | 0.81045793 |
| 131 | MP0003868_abnormal_feces_composition | 0.80680798 |
| 132 | MP0008995_early_reproductive_senescence | 0.80632418 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.80305436 |
| 134 | MP0003787_abnormal_imprinting | 0.80150722 |
| 135 | MP0001944_abnormal_pancreas_morphology | 0.80042657 |
| 136 | MP0005166_decreased_susceptibility_to | 0.79757852 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.79409040 |
| 138 | MP0004885_abnormal_endolymph | 0.78865144 |
| 139 | MP0003045_fibrosis | 0.78560938 |
| 140 | MP0000371_diluted_coat_color | 0.78386143 |
| 141 | MP0009115_abnormal_fat_cell | 0.78191157 |
| 142 | MP0004130_abnormal_muscle_cell | 0.77886762 |
| 143 | MP0002933_joint_inflammation | 0.77769357 |
| 144 | MP0005023_abnormal_wound_healing | 0.77347811 |
| 145 | MP0002736_abnormal_nociception_after | 0.77195550 |
| 146 | MP0003633_abnormal_nervous_system | 0.76426557 |
| 147 | MP0004185_abnormal_adipocyte_glucose | 0.76015303 |
| 148 | MP0005535_abnormal_body_temperature | 0.74886931 |
| 149 | MP0003828_pulmonary_edema | 0.74842837 |
| 150 | MP0003690_abnormal_glial_cell | 0.74582613 |
| 151 | MP0003795_abnormal_bone_structure | 0.74571558 |
| 152 | MP0002419_abnormal_innate_immunity | 0.74461379 |
| 153 | MP0000747_muscle_weakness | 0.73814382 |
| 154 | MP0003959_abnormal_lean_body | 0.73465705 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.72141051 |
| 156 | MP0001485_abnormal_pinna_reflex | 0.72088521 |
| 157 | MP0001800_abnormal_humoral_immune | 0.71522921 |
| 158 | MP0003866_abnormal_defecation | 0.69827707 |
| 159 | MP0005165_increased_susceptibility_to | 0.69527781 |
| 160 | MP0001963_abnormal_hearing_physiology | 0.68648011 |
| 161 | MP0002723_abnormal_immune_serum | 0.68222017 |
| 162 | MP0002733_abnormal_thermal_nociception | 0.68040682 |
| 163 | MP0003763_abnormal_thymus_physiology | 0.67906918 |
| 164 | MP0005379_endocrine/exocrine_gland_phen | 0.67547319 |
| 165 | MP0001663_abnormal_digestive_system | 0.65973270 |
| 166 | MP0002971_abnormal_brown_adipose | 0.64752013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.22684602 |
| 2 | Testicular atrophy (HP:0000029) | 4.06438168 |
| 3 | Ocular albinism (HP:0001107) | 3.89248813 |
| 4 | Cerebral aneurysm (HP:0004944) | 3.36953651 |
| 5 | Decreased circulating renin level (HP:0003351) | 3.36477542 |
| 6 | Iris hypopigmentation (HP:0007730) | 3.36184694 |
| 7 | Broad face (HP:0000283) | 3.18657799 |
| 8 | Abnormality of secondary sexual hair (HP:0009888) | 3.10658690 |
| 9 | Abnormality of the axillary hair (HP:0100134) | 3.10658690 |
| 10 | Joint hemorrhage (HP:0005261) | 3.08666862 |
| 11 | Glomerulonephritis (HP:0000099) | 3.07243462 |
| 12 | Thin bony cortex (HP:0002753) | 3.06470133 |
| 13 | J-shaped sella turcica (HP:0002680) | 2.98712775 |
| 14 | Absent/shortened dynein arms (HP:0200106) | 2.94398907 |
| 15 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.94398907 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.94020874 |
| 17 | Cortical visual impairment (HP:0100704) | 2.89058339 |
| 18 | Thyroid-stimulating hormone excess (HP:0002925) | 2.88008241 |
| 19 | Cervical subluxation (HP:0003308) | 2.76911554 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76677685 |
| 21 | Mucopolysacchariduria (HP:0008155) | 2.76677685 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.69895929 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.69895929 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.69895929 |
| 25 | Focal motor seizures (HP:0011153) | 2.58278757 |
| 26 | Menorrhagia (HP:0000132) | 2.58073722 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.57858111 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 2.57759137 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56617229 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56617229 |
| 31 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.56139214 |
| 32 | Stomatitis (HP:0010280) | 2.54480643 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 2.50044194 |
| 34 | Metabolic alkalosis (HP:0200114) | 2.49814639 |
| 35 | Increased IgE level (HP:0003212) | 2.48972754 |
| 36 | Abnormality of magnesium homeostasis (HP:0004921) | 2.48251620 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 2.47724189 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.45502935 |
| 39 | Optic nerve hypoplasia (HP:0000609) | 2.45267408 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.44147218 |
| 41 | Split foot (HP:0001839) | 2.43799682 |
| 42 | Stridor (HP:0010307) | 2.43289904 |
| 43 | Septo-optic dysplasia (HP:0100842) | 2.42232763 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.41569876 |
| 45 | Abnormality of renin-angiotensin system (HP:0000847) | 2.40541603 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.40422438 |
| 47 | Onion bulb formation (HP:0003383) | 2.40080053 |
| 48 | Sleep apnea (HP:0010535) | 2.39794406 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.38437955 |
| 50 | Thoracic kyphosis (HP:0002942) | 2.36587798 |
| 51 | Joint stiffness (HP:0001387) | 2.36065493 |
| 52 | Recurrent abscess formation (HP:0002722) | 2.34989669 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.34426504 |
| 54 | Obstructive lung disease (HP:0006536) | 2.33771830 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33771830 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.32857169 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.31959813 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.31694941 |
| 59 | Myositis (HP:0100614) | 2.30836648 |
| 60 | Increased connective tissue (HP:0009025) | 2.29525653 |
| 61 | Hyperacusis (HP:0010780) | 2.29081012 |
| 62 | Biconcave vertebral bodies (HP:0004586) | 2.27516461 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.27385877 |
| 64 | Nasal polyposis (HP:0100582) | 2.25079121 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24287767 |
| 66 | Ulnar claw (HP:0001178) | 2.23829429 |
| 67 | Reticulocytopenia (HP:0001896) | 2.23550307 |
| 68 | Emphysema (HP:0002097) | 2.22136396 |
| 69 | Abnormal sex determination (HP:0012244) | 2.21828394 |
| 70 | Sex reversal (HP:0012245) | 2.21828394 |
| 71 | Cellulitis (HP:0100658) | 2.21546250 |
| 72 | Nonprogressive disorder (HP:0003680) | 2.20647940 |
| 73 | Hemiplegia (HP:0002301) | 2.20266656 |
| 74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18172103 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18172103 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18172103 |
| 77 | Nuclear cataract (HP:0100018) | 2.16967905 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.15813566 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15273815 |
| 80 | Aneurysm (HP:0002617) | 2.13826560 |
| 81 | Inflammation of the large intestine (HP:0002037) | 2.11330541 |
| 82 | Exercise-induced myalgia (HP:0003738) | 2.10782127 |
| 83 | Abnormality of complement system (HP:0005339) | 2.09787474 |
| 84 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.08991252 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 2.06998363 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.04933823 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03976794 |
| 88 | Scanning speech (HP:0002168) | 2.01745052 |
| 89 | Meningitis (HP:0001287) | 2.01443172 |
| 90 | Mitral regurgitation (HP:0001653) | 2.00917315 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.00466570 |
| 92 | Prolonged bleeding time (HP:0003010) | 1.99966507 |
| 93 | Mediastinal lymphadenopathy (HP:0100721) | 1.99096841 |
| 94 | Malnutrition (HP:0004395) | 1.98847813 |
| 95 | Lymphangioma (HP:0100764) | 1.98435431 |
| 96 | Abnormal ciliary motility (HP:0012262) | 1.97189130 |
| 97 | Duplicated collecting system (HP:0000081) | 1.97070533 |
| 98 | Deformed sella turcica (HP:0002681) | 1.96917162 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95714150 |
| 100 | Absent speech (HP:0001344) | 1.95010749 |
| 101 | Annular pancreas (HP:0001734) | 1.94856069 |
| 102 | Polygenic inheritance (HP:0010982) | 1.94446763 |
| 103 | Aplasia cutis congenita (HP:0001057) | 1.94211722 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 1.94041829 |
| 105 | Febrile seizures (HP:0002373) | 1.93950798 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93703215 |
| 107 | Easy fatigability (HP:0003388) | 1.93236693 |
| 108 | Eczematoid dermatitis (HP:0000976) | 1.93169194 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 1.92383159 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.92183872 |
| 111 | Pustule (HP:0200039) | 1.92130771 |
| 112 | Hyperkalemia (HP:0002153) | 1.92092306 |
| 113 | Amyloidosis (HP:0011034) | 1.91917629 |
| 114 | Hypomagnesemia (HP:0002917) | 1.91868436 |
| 115 | Complement deficiency (HP:0004431) | 1.91586696 |
| 116 | Chronic otitis media (HP:0000389) | 1.90926960 |
| 117 | Loss of speech (HP:0002371) | 1.90738618 |
| 118 | Abnormality of the renal collecting system (HP:0004742) | 1.90185410 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90131713 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.89152283 |
| 121 | Supranuclear gaze palsy (HP:0000605) | 1.88123632 |
| 122 | Distal upper limb amyotrophy (HP:0007149) | 1.87974504 |
| 123 | Upper limb amyotrophy (HP:0009129) | 1.87974504 |
| 124 | Hypertriglyceridemia (HP:0002155) | 1.87773226 |
| 125 | Vertebral compression fractures (HP:0002953) | 1.87627858 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87592843 |
| 127 | Bradycardia (HP:0001662) | 1.87485821 |
| 128 | Agitation (HP:0000713) | 1.87211539 |
| 129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85802846 |
| 130 | Metaphyseal cupping (HP:0003021) | 1.85446807 |
| 131 | Nephritis (HP:0000123) | 1.84309650 |
| 132 | Colitis (HP:0002583) | 1.84210462 |
| 133 | Orchitis (HP:0100796) | 1.82133583 |
| 134 | Papilledema (HP:0001085) | 1.81906912 |
| 135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81887982 |
| 136 | Disproportionate tall stature (HP:0001519) | 1.81753546 |
| 137 | Type I transferrin isoform profile (HP:0003642) | 1.81410664 |
| 138 | Flat acetabular roof (HP:0003180) | 1.79962691 |
| 139 | Tubulointerstitial nephritis (HP:0001970) | 1.79186641 |
| 140 | Spinal canal stenosis (HP:0003416) | 1.79137882 |
| 141 | Gastrointestinal stroma tumor (HP:0100723) | 1.79105637 |
| 142 | Stage 5 chronic kidney disease (HP:0003774) | 1.77762683 |
| 143 | Aortic regurgitation (HP:0001659) | 1.77156456 |
| 144 | Upper limb muscle weakness (HP:0003484) | 1.75883194 |
| 145 | Distal lower limb amyotrophy (HP:0008944) | 1.75448295 |
| 146 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74929444 |
| 147 | Flat occiput (HP:0005469) | 1.74825906 |
| 148 | Craniofacial hyperostosis (HP:0004493) | 1.73633406 |
| 149 | Cerebral inclusion bodies (HP:0100314) | 1.73152739 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.72936550 |
| 151 | Restrictive lung disease (HP:0002091) | 1.72924219 |
| 152 | Dilatation of the ascending aorta (HP:0005111) | 1.71511425 |
| 153 | Increased serum ferritin (HP:0003281) | 1.71444081 |
| 154 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71282488 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.71209942 |
| 156 | Decreased central vision (HP:0007663) | 1.71032038 |
| 157 | Spontaneous hematomas (HP:0007420) | 1.70945952 |
| 158 | Hemoptysis (HP:0002105) | 1.70892831 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.70793682 |
| 160 | Purpura (HP:0000979) | 1.70470851 |
| 161 | Gaze-evoked nystagmus (HP:0000640) | 1.70236756 |
| 162 | Ulnar bowing (HP:0003031) | 1.69595878 |
| 163 | Large eyes (HP:0001090) | 1.68852437 |
| 164 | Concave nail (HP:0001598) | 1.66548920 |
| 165 | Epistaxis (HP:0000421) | 1.65202798 |
| 166 | Cerebral palsy (HP:0100021) | 1.64672758 |
| 167 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.64105452 |
| 168 | Generalized hypopigmentation of hair (HP:0011358) | 1.63428872 |
| 169 | Gingivitis (HP:0000230) | 1.62428868 |
| 170 | Dry hair (HP:0011359) | 1.62184283 |
| 171 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.62142431 |
| 172 | Esotropia (HP:0000565) | 1.61367478 |
| 173 | Abnormality of DNA repair (HP:0003254) | 1.61296266 |
| 174 | Recurrent fungal infections (HP:0002841) | 1.59090012 |
| 175 | Hyperparathyroidism (HP:0000843) | 1.58940329 |
| 176 | Recurrent skin infections (HP:0001581) | 1.57893569 |
| 177 | Abnormality of chloride homeostasis (HP:0011422) | 1.55136334 |
| 178 | Unilateral renal agenesis (HP:0000122) | 1.54763672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.96619562 |
| 2 | TRIB3 | 4.50860628 |
| 3 | PRPF4B | 3.27577224 |
| 4 | TLK1 | 3.19172676 |
| 5 | FES | 2.99014089 |
| 6 | BLK | 2.95205410 |
| 7 | ERN1 | 2.82307337 |
| 8 | TNIK | 2.59535812 |
| 9 | MKNK2 | 2.45371297 |
| 10 | PHKG1 | 2.42688359 |
| 11 | PHKG2 | 2.42688359 |
| 12 | PRKD2 | 2.31608442 |
| 13 | MAP2K3 | 2.28639995 |
| 14 | INSRR | 2.26276140 |
| 15 | TAOK3 | 2.01825962 |
| 16 | RIPK1 | 1.98690006 |
| 17 | FER | 1.96717507 |
| 18 | EEF2K | 1.90848534 |
| 19 | ICK | 1.84758418 |
| 20 | MAPK15 | 1.83566580 |
| 21 | SMG1 | 1.80225527 |
| 22 | IRAK3 | 1.76575807 |
| 23 | PKN1 | 1.74916483 |
| 24 | NLK | 1.67792103 |
| 25 | SIK2 | 1.66063431 |
| 26 | STK38 | 1.62228743 |
| 27 | PKN2 | 1.61837085 |
| 28 | IRAK4 | 1.58156281 |
| 29 | MARK2 | 1.48400686 |
| 30 | CAMK1G | 1.42711136 |
| 31 | IRAK1 | 1.38422928 |
| 32 | CDK12 | 1.35138631 |
| 33 | MAP3K6 | 1.32782251 |
| 34 | IRAK2 | 1.26599364 |
| 35 | PDGFRA | 1.25176734 |
| 36 | RIPK4 | 1.23150028 |
| 37 | JAK3 | 1.18402600 |
| 38 | CAMK1 | 1.17109944 |
| 39 | EPHB1 | 1.16662706 |
| 40 | CAMKK2 | 1.16338440 |
| 41 | TNK2 | 1.13954868 |
| 42 | HIPK2 | 1.12009399 |
| 43 | CSK | 1.11119375 |
| 44 | IKBKE | 1.09487467 |
| 45 | MAP2K6 | 1.09459145 |
| 46 | CLK1 | 1.09445964 |
| 47 | NTRK3 | 1.07221390 |
| 48 | MAPK7 | 1.05685740 |
| 49 | MAP3K7 | 1.05411770 |
| 50 | PTK6 | 1.05290303 |
| 51 | UHMK1 | 1.04505311 |
| 52 | DAPK2 | 1.03914849 |
| 53 | PDPK1 | 1.02310506 |
| 54 | MAP3K11 | 1.01915582 |
| 55 | HCK | 1.01538597 |
| 56 | STK11 | 1.00995548 |
| 57 | DAPK3 | 0.99265132 |
| 58 | GRK1 | 0.97738060 |
| 59 | PRKAA2 | 0.97259460 |
| 60 | MAP3K3 | 0.95399990 |
| 61 | RPS6KL1 | 0.92892357 |
| 62 | RPS6KC1 | 0.92892357 |
| 63 | GRK6 | 0.92804633 |
| 64 | MAP4K1 | 0.92616663 |
| 65 | DDR2 | 0.92603719 |
| 66 | CDK19 | 0.92473189 |
| 67 | FGFR3 | 0.92349370 |
| 68 | TYRO3 | 0.90244309 |
| 69 | SIK3 | 0.88454872 |
| 70 | PRKD1 | 0.87663667 |
| 71 | MTOR | 0.87376948 |
| 72 | MAP3K10 | 0.86947137 |
| 73 | KIT | 0.86168851 |
| 74 | LMTK2 | 0.85167359 |
| 75 | MAP3K13 | 0.84604700 |
| 76 | PDK1 | 0.83838300 |
| 77 | CAMK1D | 0.82413559 |
| 78 | MAPK11 | 0.81278397 |
| 79 | TXK | 0.78129610 |
| 80 | JAK1 | 0.78012049 |
| 81 | WNK1 | 0.77419875 |
| 82 | RPS6KA6 | 0.75795406 |
| 83 | RET | 0.75294649 |
| 84 | SIK1 | 0.75222151 |
| 85 | ITK | 0.74366205 |
| 86 | MAP3K1 | 0.74032957 |
| 87 | MUSK | 0.73960412 |
| 88 | BMX | 0.71720498 |
| 89 | CSF1R | 0.71196521 |
| 90 | MKNK1 | 0.71058458 |
| 91 | KSR2 | 0.70080679 |
| 92 | TAOK1 | 0.70080572 |
| 93 | CAMKK1 | 0.68834736 |
| 94 | FGFR4 | 0.68547082 |
| 95 | CAMK2B | 0.67900135 |
| 96 | PRKCH | 0.67010781 |
| 97 | WNK4 | 0.65290927 |
| 98 | MAP2K2 | 0.64506395 |
| 99 | TYK2 | 0.64152247 |
| 100 | LCK | 0.64055678 |
| 101 | PDGFRB | 0.63103959 |
| 102 | MAP3K14 | 0.62647789 |
| 103 | YES1 | 0.62383426 |
| 104 | TGFBR2 | 0.62009856 |
| 105 | BTK | 0.61101594 |
| 106 | PRKD3 | 0.60467119 |
| 107 | IKBKB | 0.59842923 |
| 108 | TEC | 0.59467928 |
| 109 | SYK | 0.59153013 |
| 110 | STK39 | 0.58731938 |
| 111 | TAOK2 | 0.58681736 |
| 112 | PAK2 | 0.57148868 |
| 113 | DYRK1B | 0.56694160 |
| 114 | GRK7 | 0.55893064 |
| 115 | CAMK4 | 0.54777276 |
| 116 | ADRBK2 | 0.53874943 |
| 117 | MAPK12 | 0.51349334 |
| 118 | FGR | 0.50343081 |
| 119 | TTN | 0.49007187 |
| 120 | EPHA4 | 0.48880188 |
| 121 | MAPK4 | 0.48821011 |
| 122 | CHUK | 0.48380927 |
| 123 | ZAP70 | 0.48097468 |
| 124 | MAP2K7 | 0.47768246 |
| 125 | TBK1 | 0.47442901 |
| 126 | LYN | 0.47221088 |
| 127 | NTRK2 | 0.47127349 |
| 128 | FYN | 0.46471314 |
| 129 | SGK3 | 0.45707962 |
| 130 | MARK3 | 0.45653419 |
| 131 | PIK3CG | 0.45568831 |
| 132 | BRD4 | 0.44220172 |
| 133 | RPS6KA2 | 0.42667424 |
| 134 | CDC42BPA | 0.41169273 |
| 135 | TRPM7 | 0.40643957 |
| 136 | DMPK | 0.40600808 |
| 137 | PRKG1 | 0.40510445 |
| 138 | MAPK3 | 0.40401015 |
| 139 | CDK5 | 0.40194627 |
| 140 | EIF2AK2 | 0.40060132 |
| 141 | CDK9 | 0.39279547 |
| 142 | NTRK1 | 0.38779335 |
| 143 | DYRK1A | 0.38116744 |
| 144 | CDK4 | 0.37943544 |
| 145 | STK16 | 0.37935572 |
| 146 | NME2 | 0.37499728 |
| 147 | JAK2 | 0.37082283 |
| 148 | MAPK8 | 0.36695247 |
| 149 | PINK1 | 0.35593286 |
| 150 | EPHA3 | 0.35274203 |
| 151 | ERBB2 | 0.33754791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Morphine addiction_Homo sapiens_hsa05032 | 1.94363984 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.88186946 |
| 3 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.77741198 |
| 4 | Taste transduction_Homo sapiens_hsa04742 | 1.75940062 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.70246862 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 1.70144797 |
| 7 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67791683 |
| 8 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.67226552 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 1.63551370 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.59593381 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58768595 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58261120 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54268346 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.50347740 |
| 15 | * Other glycan degradation_Homo sapiens_hsa00511 | 1.47109963 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.46768932 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.46511308 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46435430 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41509717 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.40963692 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40036980 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.39868001 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39746541 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39172724 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.39155793 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36970194 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36738144 |
| 28 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36291921 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36123533 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35376994 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.32131051 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32013709 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.30792439 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30376449 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28956723 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26491906 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25837419 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25655633 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24529377 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24353432 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22931535 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.22504088 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21988213 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.18468164 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18385757 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.17889239 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.16256635 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15049851 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.14905596 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14343884 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14109774 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13172944 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 1.10271113 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06168480 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05777829 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.04953239 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04685817 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.03043225 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02549728 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 1.00725640 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 1.00122509 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.99621968 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.99435197 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.98249671 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97778242 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97337889 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.96260394 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.94841374 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94059692 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92854846 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91663167 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91578586 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90921780 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89827554 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.89422372 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88462128 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87801976 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87645699 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.87158145 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87015384 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86658989 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86086786 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85921757 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85906105 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85055751 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84603879 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83402146 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83069279 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82285560 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.82100513 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81897971 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80651303 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78295261 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74861633 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74840957 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.74371865 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74340934 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73875873 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71732039 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71671522 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71667696 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70714434 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68996353 |
| 104 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68925214 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.68669828 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68666033 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68603712 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67936211 |
| 109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67433913 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67247473 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67153893 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.65113792 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.65016369 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64521238 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.64038404 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63671902 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.63621868 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63498878 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62907608 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61292622 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61129792 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59422241 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58928370 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.57098461 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56739197 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56718855 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56576244 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55973509 |
| 129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55648202 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55612006 |
| 131 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55363740 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55080065 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54238376 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53982595 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53910305 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.53888270 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53306287 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52795624 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52057528 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51905970 |
| 141 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51351910 |
| 142 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.51120018 |
| 143 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51005859 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.50740699 |
| 145 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50714211 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50408368 |
| 147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48319601 |
| 148 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47545624 |
| 149 | Malaria_Homo sapiens_hsa05144 | 0.46679740 |
| 150 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45344814 |
| 151 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44935322 |
| 152 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44739371 |
| 153 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44304650 |

